Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Looking At Google Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Alphabet (NASDAQ:GOOGL). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Mid-Morning Market Update: Markets Open Lower; Dow Dips 300 Points

Mid-Morning Market Update: Markets Open Lower; Dow Dips 300 Points

U.S. stocks traded lower this morning, with the Dow Jones dropping around 300 points on Tuesday.

Earnings Outlook For T-Mobile US

Earnings Outlook For T-Mobile US

T-Mobile US (NASDAQ:TMUS) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that T-Mobile US will report an earnings per share (EPS) of $0.32.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Earnings Outlook For Old Dominion Freight

Old Dominion Freight (NASDAQ:ODFL) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Old Dominion Freight will report an earnings per share (EPS) of $2.39.

Earnings Preview: Amgen

Amgen (NASDAQ:AMGN) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Amgen will report an earnings per share (EPS) of $4.15.

NVIDIA Whale Trades For April 26

A whale with a lot of money to spend has taken a noticeably bearish stance on NVIDIA. Looking at options history for NVIDIA (NASDAQ:NVDA) we detected 23 strange trades.

Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2022

Upgrades According to Susquehanna, the prior rating for Boyd Gaming Corp (NYSE:BYD) was changed from Neutral to Positive. At the moment, the stock has a 52-week-high of $72.72 and a 52-week-low of $50.38. Boyd Gaming closed at $64.20 at the end of the last trading period.

inkl

Read news from The Economist, FT, and more,
with one subscription

Earnings Outlook For Seagate Technology

Earnings Outlook For Seagate Technology

Seagate Technology (NASDAQ:STX) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Seagate Technology will report an earnings per share (EPS) of $1.89.

Coinbase Global Whale Trades For April 26

Coinbase Global Whale Trades For April 26

Someone with a lot of money to spend has taken a bearish stance on Coinbase Global (NASDAQ:COIN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Analyst Ratings for Frontier Communications

Analyst Ratings for Frontier Communications

Over the past 3 months, 5 analysts have published their opinion on Frontier Communications (NASDAQ:FYBR) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Earnings Outlook For Meta Platforms

Earnings Outlook For Meta Platforms

Meta Platforms (NASDAQ:FB) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Meta Platforms will report an earnings per share (EPS) of $2.56.

Check Out What Whales Are Doing With ASML

Check Out What Whales Are Doing With ASML

A whale with a lot of money to spend has taken a noticeably bullish stance on ASML Holding. Looking at options history for ASML Holding (NASDAQ:ASML) we detected 13 strange trades.

Expert Ratings for Newmark Group

Expert Ratings for Newmark Group

Over the past 3 months, 4 analysts have published their opinion on Newmark Group (NASDAQ:NMRK) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

What 4 Analyst Ratings Have To Say About The Middleby

What 4 Analyst Ratings Have To Say About The Middleby

Within the last quarter, The Middleby (NASDAQ:MIDD) has observed the following analyst ratings:

Get all your
news in one place.

100's of premium titles.
One news app.

Tenon Medical, Inc To Start Trading Tomorrow

Tenon Medical, Inc (NASDAQ:TNON) IPO will take place April, 27 on the NASDAQ exchange under the ticker TNON. The company is offering shares at an expected price between $4.50 and $5.50 per share with an insider lock-up period of 180 days ending on October 24, 2022.

Preview: Innovative Eyewear, Inc. Set To IPO Tomorrow

Innovative Eyewear, Inc. (NASDAQ:LUCY) IPO will take place April, 27 on the NASDAQ exchange under the ticker LUCY. The company is offering shares at an expected price between $5.50 and $7.50 per share with an insider lock-up period of 180 days ending on October 24, 2022.

Looking Into Global Blood Therapeutics's Return On Capital Employed

Global Blood Therapeutics (NASDAQ:GBT) brought in sales totaling $56.10 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 23.37%, resulting in a loss of $87.58 million.

Heidrick & Struggles Intl Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q1, Heidrick & Struggles Intl (NASDAQ:HSII) earned $18.47 million, a 48.01% increase from the preceding quarter. Heidrick & Struggles Intl's sales decreased to $283.86 million, a 0.59% change since Q4.

Get all your
news in one place.

100's of premium titles.
One news app.

Dorman Products's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, Dorman Products (NASDAQ:DORM) earned $35.21 million, a 3.31% increase from the preceding quarter. Dorman Products also posted a total of $401.58 million in sales, a 0.85% increase since Q4.

Recap: Bank7 Q1 Earnings

Bank7 (NASDAQ:BSVN) reported its Q1 earnings results on Tuesday, April 26, 2022 at 09:00 AM. Here's what investors need to know about the announcement.

Looking Into Cadence Design Systems's Return On Capital Employed

According to Benzinga Pro, during Q1, Cadence Design Systems (NASDAQ:CDNS) earned $235.34 million, a 33.27% increase from the preceding quarter. Cadence Design Systems also posted a total of $901.77 million in sales, a 16.65% increase since Q4.

Prothena Receives FDA Fast Track Designation for PRX012 for the Treatment of Alzheimer's Disease

Prothena Corporation plc (NASDAQ: PRTA) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the anti-amyloid beta (Aβ) antibody therapy drug candidate PRX012 for the treatment of Alzheimer's disease.

Benzinga's Daily Brief On Trending Tickers For April 26, 2022: Raytheon, GE, Warner Bros., Digital World Acquisition And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.

India Tries To Attract Intel, TSMC, GlobalFoundries To Set Up Local Plant

India is in talks with global chipmakers Intel Corp (NASDAQ:INTC), GlobalFoundries Inc (NASDAQ:GFS), and Taiwan Semiconductor Manufacturing Co Ltd (NYSE:TSM) about setting up local operations, Bloomberg reports. India aspires to become an electronic hub like neighbor China, Bloomberg notes. In India, a venture between billionaire Anil Agarwal’s Vedanta Group and Apple Inc (NASDAQ:AAPL) supplier Hon Hai Precision Industry Co Ltd (OTC:HNHPF),…

Gamida Cell Shares Jump On FDA Nod To Cell Therapy Trial In Blood Cancer Settings

The FDA has signed off and removed the clinical hold for a cryopreserved formulation of Gamida Cell Ltd's (NASDAQ:GMDA) GDA-201, an off-the-shelf cell therapy candidate for follicular and diffuse large B cell lymphomas. Gamida Cell expects to initiate a Phase 1/2 clinical study in patients with follicular and diffuse large B-cell lymphomas in 2022.…

1 … 689 690 691 692

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Intel Corporation

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

394,813 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play